These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30621577)

  • 1. Identifying genes with tri-modal association with survival and tumor grade in cancer patients.
    Zhang M; Wang T; Sirianni R; Shaul PW; Xie Y
    BMC Bioinformatics; 2019 Jan; 20(1):13. PubMed ID: 30621577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
    Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH
    Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes expand during evolution to withstand somatic amplification.
    Wang X; Li X; Zhang L; Wong SH; Wang MHT; Tse G; Dai RZW; Nakatsu G; Coker OO; Chen Z; Ko H; Chan JYK; Liu T; Cheng CHK; Cheng ASL; To KF; Plewczynski D; Sung JJY; Yu J; Gin T; Chan MTV; Wu WKK
    Ann Oncol; 2018 Nov; 29(11):2254-2260. PubMed ID: 30204835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.
    Huang Z; Duan H; Li H
    Biomed Res Int; 2015; 2015():878546. PubMed ID: 26576432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX
    Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1.
    Zeng H; Irwin ML; Lu L; Risch H; Mayne S; Mu L; Deng Q; Scarampi L; Mitidieri M; Katsaros D; Yu H
    Breast Cancer Res Treat; 2012 May; 133(1):127-35. PubMed ID: 21837478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
    Guest ST; Kratche ZR; Bollig-Fischer A; Haddad R; Ethier SP
    Exp Cell Res; 2015 Mar; 332(2):223-35. PubMed ID: 25704758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of proto-oncogene activation in carcinogenesis.
    Anderson MW; Reynolds SH; You M; Maronpot RM
    Environ Health Perspect; 1992 Nov; 98():13-24. PubMed ID: 1486840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method.
    Amgalan B; Lee H
    Bioinformatics; 2015 Aug; 31(15):2452-60. PubMed ID: 25819079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From oncogene to network addiction: the new frontier of cancer genomics and therapeutics.
    Tonon G
    Future Oncol; 2008 Aug; 4(4):569-77. PubMed ID: 18684067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards an extension of the two-variable model of carcinogenesis through oncogenes and tumour suppressor genes.
    Tourvas AD; Frangos CC
    Med Hypotheses; 2011 Dec; 77(6):956-8. PubMed ID: 21903334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA function in cancer: oncogene or a tumor suppressor?
    Shenouda SK; Alahari SK
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes.
    Moelans CB; van der Groep P; Hoefnagel LDC; van de Vijver MJ; Wesseling P; Wesseling J; van der Wall E; van Diest PJ
    Cancer Lett; 2014 Mar; 344(1):138-146. PubMed ID: 24184827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of oncogene-induced cancer.
    Felsher DW
    Curr Opin Genet Dev; 2004 Feb; 14(1):37-42. PubMed ID: 15108803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Oncogenic and Tumor Suppressor Role of XPO5 in Different Tissue Tumor Types.
    Khan M; Khan Z; Uddin Y; Mustafa S; Shaukat I; Pan J; Höti N
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1119-1125. PubMed ID: 29699373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.